Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - lenalidomidum - gélules - lenalidomidum 25 mg, lactosum 200 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium max. 1.08 mg, magnesii stearas, gelatina, e 171, aqua purificata, pro capsula. - onkologikum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsules - lenalidomidum 2.5 mg, cellulosum microcristallinum, lactosum 33.2 mg, carmellosum natricum conexum corresp. natrium 0.089 mg, magnesii stearas, gelatina, e 171, e 172 (flavum), e 132, lacca, drucktinte: e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsules - lenalidomidum 5 mg, cellulosum microcristallinum, lactosum 66.4 mg, carmellosum natricum conexum, natrium 0.178 mg, magnesii stearas, gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsules - lenalidomidum 7.5 mg, cellulosum microcristallinum, lactosum 99.7 mg, carmellosum natricum conexum corresp. natrium 0.266 mg, magnesii stearas, gelatina, e 171, e 172 (flavum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsules - lenalidomidum 10 mg, cellulosum microcristallinum, lactosum 132.9 mg, carmellosum natricum conexum corresp. natrium 0.355 mg, magnesii stearas, gelatina, e 171, e 172 (flavum), e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsules - lenalidomidum 15 mg, cellulosum microcristallinum, lactosum 199.3 mg, carmellosum natricum conexum corresp. natrium 0.539 mg, magnesii stearas, gelatina, e 171, e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsules - lenalidomidum 20 mg, cellulosum microcristallinum, lactosum 265.8 mg, carmellosum natricum conexum corresp. natrium 0.716 mg, magnesii stearas, gelatina, e 171, e 172 (flavum), e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsules - lenalidomidum 25 mg, cellulosum microcristallinum, lactosum 332.2 mg, carmellosum natricum conexum corresp. natrium 0.894 mg, magnesii stearas, gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - bevacizumabum - solution à diluer pour perfusion - bevacizumabum 100 mg, acidum succinicum, saccharum, dinatrii edetas, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 2.32 mg. - onkologikum - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - bevacizumabum - solution à diluer pour perfusion - bevacizumabum 400 mg, acidum succinicum, saccharum, dinatrii edetas, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 9.29 mg. - onkologikum - biotechnologika